The Paradox Of Today's Chemistry Profession

By many measures, chemistry is the central and most successful of all sciences--in the world at large and supremely in the United States. America boasts an enviable record of Nobel laureates in chemistry over the past three decades; the chemical process industries routinely compile trade surpluses of billions of dollars; and the American Chemical Society is the world's largest single-discipline scientific society. And yet, and yet... Chemists see themselves as beleaguered, unloved, unappreciat

Written byArnold Thackray
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Chemists see themselves as beleaguered, unloved, unappreciated. Undergraduates turn away from a chemistry major, and graduate assistantships go begging. Chemistry possesses no federal project on the order of the genome initiative or superconducting supercollider, and industrial chemists in midcareer find themselves the object of corporate "repositionings" and other euphemisms for unemployment.

Meanwhile, for the rest of the world, "chemical" has become a synonym for "bad" (as in chemical dependency, or chemical additive), lawsuits multiply on issues like Agent Orange, and it is difficult for the ordinary citizen to believe that--with acid rain, global warming, toxic waste, and chemical carcinogens--all is well.

The simple truth is that the chemical sciences are in robust health, that chemists and chemical engineers become ever more vital to our civilization with every passing year, and that the promises of "better things for better living through chemistry" have never been more appropriate. Alas, the truth is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies